Kwangdong Pharmaceutical (009290) held a Compliance Committee workshop to review the risk of legal violations and corruption in each of its business divisions and to strengthen internal auditing capabilities. The aim was to identify in advance the risks that can arise when applying its fair trade compliance program (CP) to day-to-day operations.
The company said on the 30th that it held a two-day, one-night workshop for members of the Compliance Committee, its internal audit body for anti-corruption. The program focused on strengthening the CP risk assessment skills of committee members representing each business division and on deepening their practical understanding of the anti-bribery management system (ISO 37001) and the compliance management system (ISO 37301).
The workshop opened with remarks from the chief executive and the compliance officer, followed by ISO internal auditor training and a mock internal audit simulating an actual inspection. Participants examined the risks of legal violations and corruption that can arise in each department's work processes and discussed how to respond. A separate session shared the committee's operating direction going forward and the status of compliance activities by division.
"This workshop was a process for reviewing our practical internal audit capabilities and embedding a company-wide compliance system in day-to-day operations," an official at Kwangdong Pharmaceutical said. "We will continue systematic reviews and training to prevent corruption risks within the company in advance and to establish compliance management."
Earlier this year, Kwangdong Pharmaceutical expanded its existing CP office into a division-level organization and placed it directly under the chief executive, strengthening the independence and execution capacity of its audit and control functions. In June, it elevated the anti-corruption subcommittee, which had operated since 2021, to the Compliance Committee, and designated and declared June 2 of each year as "Ethics Day" as part of continuing efforts to spread a culture of compliance within the company.
